Recent Quarter Total Invested
$624.45 M
Recent Quarter Institutional Ownership Percentage
103.86%
Total Invested of Last Quarter
$1.20 B
Ownership Percentage of Last Quarter
116.37%
4D Molecular Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2024 | 7.38 M | $79.81 M | 88.22% | 13.29% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 5.10 M | $55.11 M | 0.00% | 9.18% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.87 M | $52.63 M | 100.00% | 8.76% |
| VR ADVISER, LLC | 11/14/2024 | 4.40 M | $47.56 M | 0.00% | 7.92% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 4.10 M | $44.28 M | 0.86% | 7.37% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 3.59 M | $38.82 M | -13.14% | 6.46% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 3.14 M | $33.92 M | -1.87% | 5.65% |
| STATE STREET CORP | 11/14/2024 | 2.12 M | $22.88 M | 1.79% | 3.81% |
| MORGAN STANLEY | 11/14/2024 | 1.70 M | $18.40 M | 16.58% | 3.06% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.54 M | $16.68 M | 238.27% | 2.78% |
| NOVO HOLDINGS A/S | 10/24/2024 | 1.50 M | $16.22 M | 7.14% | 2.70% |
| REDMILE GROUP, LLC | 11/14/2024 | 1.26 M | $13.64 M | 17.57% | 2.27% |
| BRAIDWELL LP | 11/14/2024 | 1.23 M | $13.25 M | 231.69% | 2.21% |
| CASDIN CAPITAL, LLC | 11/14/2024 | 1.15 M | $12.43 M | 43.75% | 2.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.04 M | $11.21 M | -2.29% | 1.87% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 838,492 | $9.06 M | -51.94% | 1.51% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 803,490 | $8.69 M | -5.49% | 1.45% |
| EAGLE HEALTH INVESTMENTS LP | 11/12/2024 | 462,911 | $5.00 M | 0.00% | 0.83% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 11/13/2024 | 459,000 | $4.96 M | -34.99% | 0.83% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 422,856 | $4.57 M | -52.01% | 0.76% |
| DECHENG CAPITAL LLC | 11/15/2024 | 397,835 | $4.30 M | 14.37% | 0.72% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 351,653 | $3.80 M | 98.94% | 0.63% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 338,317 | $3.66 M | 0.13% | 0.61% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 336,000 | $3.63 M | 100.00% | 0.60% |
| JPMORGAN CHASE & CO | 11/08/2024 | 315,983 | $3.42 M | -8.62% | 0.57% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 290,031 | $3.14 M | -19.81% | 0.52% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 256,995 | $2.78 M | 12.92% | 0.46% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 208,815 | $2.26 M | -60.80% | 0.38% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 166,190 | $1.80 M | -7.39% | 0.30% |
| MARSHALL WACE, LLP | 11/14/2024 | 165,193 | $1.79 M | -11.12% | 0.30% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 161,296 | $1.74 M | 86.56% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 146,405 | $1.58 M | -13.58% | 0.26% |
| PERIGON WEALTH MANAGEMENT, LLC | 10/16/2024 | 146,170 | $1.58 M | 0.00% | 0.26% |
| CITADEL ADVISORS LLC | 11/14/2024 | 127,648 | $1.38 M | 74.39% | 0.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 123,468 | $1.33 M | 0.00% | 0.22% |
| BARCLAYS PLC | 11/19/2024 | 114,848 | $1.24 M | 141.04% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 105,972 | $1.15 M | 285.03% | 0.19% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 100,973 | $1.09 M | -71.55% | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 100,863 | $1.09 M | 175.79% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 98,800 | $1.07 M | 98.79% | 0.18% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 98,500 | $1.06 M | 146.25% | 0.18% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 90,348 | $976,662 | -5.46% | 0.16% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 84,322 | $911,521 | 100.00% | 0.15% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 83,226 | $899,673 | 145.91% | 0.15% |
| UBS GROUP AG | 11/14/2024 | 80,289 | $867,925 | 19.58% | 0.14% |
| TWINBEECH CAPITAL LP | 11/14/2024 | 76,310 | $824,911 | 30.18% | 0.14% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 75,493 | $816,079 | 157.09% | 0.14% |
| ALGERT GLOBAL LLC | 11/12/2024 | 73,436 | $794,000 | 342.71% | 0.13% |
| NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 71,000 | $767,510 | -41.32% | 0.13% |
| RHUMBLINE ADVISERS | 11/12/2024 | 69,756 | $754,052 | -4.36% | 0.13% |
4D Molecular Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of FDMT shares?
During the previous two years, 157 institutional investors and hedge funds held shares of 4D Molecular Therapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 7.38 M
RA CAPITAL MANAGEMENT, L.P.: 5.1 M
BlackRock Funding, Inc. /DE: 4.87 M
VR Adviser, LLC: 4.4 M
Deep Track Capital, LP: 4.1 M
GOLDMAN SACHS GROUP INC: 3.59 M
-
What percentage of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors?
103.86% of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at FDMT ?
Institutional investors have bought a total of 58.32 M shares in the last 24 months. This purchase volume represents approximately $454.32 M in transactions.